Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Uterine Cervical Neoplasms 2Breast Neoplasms 2Vulvar Neoplasms 1Vaginal Neoplasms 1Urinary Bladder Neoplasms 1Tobacco Use Disorder 1Stomach Neoplasms 1Smoking Cessation 1Small Cell Lung Carcinoma 1Pancreatic Neoplasms 1Overweight 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Obesity 1Neoplasms, Second Primary 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Lung Neoplasms 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Laryngeal Neoplasms 1Kidney Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Behavior, Addictive 1

Interventions

Radiotherapy 4fludarabine phosphate 2aldesleukin 2Paclitaxel 2Nivolumab 2Bevacizumab 2zimberelimab 1rocakinogene sifuplasmid 1liposomal doxorubicin 1fludarabine 1durvalumab 1dostarlimab 1belzutifan 1alovudine 1Watchful Waiting 1Vaccines, Synthetic 1VGX-3100 1Therapeutic Touch 1Specimen Handling 1Ritonavir 1Radiosurgery 1Radiation 1Peripheral Blood Stem Cell Transplantation 1Papillomavirus Vaccines 1Observation 1Mycophenolic Acid 1Magnetic Resonance Spectroscopy 1MEDI0457 1Ipilimumab 1Indinavir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Vaginal Neoplasms × Bupropion × Clear all
NCT03180294 2026-05-19

Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer

NRG Oncology

Phase 2 Completed
230 enrolled 24 charts
BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡